Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines

Background: Lung-transplant (LT) recipients are at high risk for COVID-19 due to immunosuppression and respiratory tropism of SARS-CoV-2. The information on the effect of COVID-19 mRNA vaccines to elicit immunogenic responses after a two-dose (2D) regimen in LT recipients is sparse. Thus, we assesse...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Vaccines (Basel)
Autori principali: Narasimhan, Madhusudhanan, Mahimainathan, Lenin, Clark, Andrew E, Usmani, Amena, Cao, Jing, Araj, Ellen, Torres, Fernando, Sarode, Ravi, Kaza, Vaidehi, Lacelle, Chantale, Muthukumar, Alagarraju
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310345/
https://ncbi.nlm.nih.gov/pubmed/34208884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9070708
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi